Pharmafile Logo

The challenges of conducting effective pharmaceutical market research in emerging markets

June 3, 2016 | emerging markets 

Published in Quirk’s Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets

As traditional western markets mature and there are a limited number of new products in the pipeline offering blockbuster revenues, emerging markets present an exciting opportunity for growth for the pharmaceutical industry. In the April edition of Quirks Marketing Research Review, Research Partnership’s Marc Yates provided a three-step guide to undertaking health care or pharma marketing research in non-Western markets.

http://www.researchpartnership.com/news/2016/05/article-best-practices-in-em/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Webcast:

UX beyond the website: Insights for the age of omnichannel

News:

MedTech Qualitative Specialist joins Research Partnership

Guide

How to embrace behavioural science principles in healthcare MR

Article

A glimmer of hope for Alzheimer’s patients, but at what cost?

Video

Virtual Conference Live

Report

Digital Health Tools - Physician Trends

Webcast

Oncology landscape: How innovative market research methods can navigate you to success

Article:

The disparity of patient experiences with Crohn’s Disease in Europe and Japan

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Webcast: Influencing HCP behaviours – Is now the perfect opportunity?

Putting behavioural science at the forefront of market research